目的:使用受控药物,如阿片类药物,兴奋剂,合成代谢类固醇,抑制剂,致幻剂导致了成瘾的增加,用药过量,和死亡。鉴于滥用和依赖的高属性,美国引入了处方药监测计划(PDMPs)作为州级干预措施.
方法:使用来自2019年全国电子健康档案调查的横截面数据,我们评估了PDMP使用与减少或消除受控物质处方之间的关联,以及PDMP使用与将受控物质处方改为非阿片类药物治疗或非药物治疗之间的关联.我们应用调查权重从调查样本中得出医生水平的估计值。
结果:调整医生年龄,性别,医学学位的类型,专业,和PDMP的易用性,我们发现,与报告从未使用PDMP的医师相比,报告"经常"使用PDMP的医师减少或消除受控物质处方的几率是其2.34倍(95%置信区间[CI]1.12~4.90).调整医生的年龄,性别,医生的类型,和专业,我们发现,报告"经常"使用PDMP的医师将受控物质处方改为非阿片类药物治疗或非药物治疗的奇数为3.65倍(95%CI:1.61~8.26).
结论:这些结果支持继续使用,投资,并扩大PDMPs作为减少受控物质处方和改为非阿片类/药物治疗的有效干预措施。
结论:总体而言,频繁使用PDMPs与减少,消除,或改变受控物质处方模式。
The use of controlled medications such as opioids, stimulants, anabolic steroids, depressants, and hallucinogens has led to an increase in addiction, overdose, and death. Given the high attributes of abuse and dependency, prescription drug monitoring programs (PDMPs) were introduced in the United States as a state-level intervention.
Using cross-sectional data from the 2019 National Electronic Health Records Survey, we assessed the association between PDMP usage and reduced or eliminated controlled substance prescribing as well as the association between PDMP usage and changing a controlled substance prescription to a nonopioid pharmacologic therapy or nonpharmacologic therapy. We applied survey weights to produce physician-level estimates from the survey sample.
Adjusting for physician age, sex, type of medical degree, specialty, and ease of PDMP, we found that physicians who reported \"often\" PDMP usage had 2.34 times the odds of reducing or eliminating controlled substance prescriptions compared to physicians who reported never using the PDMP (95% confidence interval [CI] 1.12-4.90). Adjusting for physician age, sex, type of doctor, and specialty, we found that physicians who reported \"often\" use of the PDMP had 3.65 times the odd of changing controlled substance prescriptions to a nonopioid pharmacologic therapy or nonpharmacologic therapy (95% CI: 1.61-8.26).
These results support the continued use, investment, and expansion of PDMPs as an effective intervention for reducing controlled substance prescription and changing to nonopioid/pharmacologic therapy.
Overall, frequent usage of PDMPs was significantly associated with reducing, eliminating, or changing controlled substance prescription patterns.